title: [Observation on two kinds of recombinant hepatitis B vaccines used in populations with different immunity].
abstract: OBJECTIVE
  To evaluate the immunity status on different hepatitis B vaccines currently being used in Beijing.
  
  
  METHODS
  College students who had not received hepatitis B vaccine and children who had received whole-course immunization at birth, were tested HBsAg, anti-HBs and anti-HBc. All the test-negative cases were served as research subjects. 3 doses recombinant hepatitis B vaccines were given to the college students, following the 0, 1, 6 months schedule. Among which, 140 cases received recombinant beer yeast hepatitis B vaccine (BY vaccine, 10 microg, 5 microg, 5 microg), and 140 cases with recombinant hansenula polymorpha hepatitis B vaccine (HP vaccine, 10 microg, 10 microg, 10 microg). 1 dose was given for boosting immunization to 98 children, in which 49 cases with BY vaccine (5 microg) and 49 cases with HP vaccine (10 microg). Anti-HBs was tested 1 month after.
  
  
  RESULTS
  The total positive (> or = 10 mIU/ ml) rate was lower among BY vaccine group than HP vaccine group for the college students (93.5 %, 99.3% , P<0.05), but no statistical difference on GMT(81.2 mIU/ml, 94.6 mIU/ml, P>0.05) was found. For males, the positive rate and GMT were lower in BY vaccine group than in HP vaccine group (85.7% ,100.0%, P<0.01)(56.6 mIU/ml, 98.6 mIU/ml, P<0.01), but with no statistical difference for females (98.8%, 98.5%, P> 0.05) (103.4 mIU/ml, 90.3 mlU/ml, P> 0.05). For the same vaccine, the positive rate and GMT were lower in males than in females when using BY vaccine (85.7% , 98.8%, P<0.01)(56.6 mIU/ml,103.4 mIU/ml, P< 0.01), but no statistical difference was found on HP vaccine(100.0%, 98.5%, P>0.05)(98.6 mIU/ml, 90.3 mIU/ml, P>0.05). The positive rate of anti-HBs was decreasing along with age among the children who had received a whole-course immunization at birth (P <0.01). 98.6 % of the 70 negative cases appeared positive conversion after receiving 1 dose and the GMT raised significantly by 15 times. No statistical difference was found between the two kinds of vaccines(100.0%, 97.4%, P>0.05)(80.5 mIU/ml, 68.5 mIU/ml, P>0.05).
  
  
  CONCLUSIONS
  The type of vaccine and sex were related to the effects, better with HP vaccine than BY vaccine in males but was the same for females in adults receiving basic immunization according to the conventional doses. Both kinds of vaccines were ideal when children receiving boosting immunization. The immune memory was good for persons who had received primary immunization with recombinant vaccine but antibody appeared negative conversion. It was not necessary to boost immunization within 6 years after a whole-course immunization with recombinant hepatitis B vaccine in infancy.
authors.affiliation: Chaoyang Center for Disease Control and Prevention, Beijing 100021, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Zhang
authors.forename: Jian-xin
authors.initials: JX
authors.lastname: Ma
authors.forename: Xiao-hong
authors.initials: XH
authors.lastname: Gong
authors.forename: Li-rong
authors.initials: LR
authors.lastname: Liu
authors.forename: Ke
authors.initials: K
authors.lastname: Wu
authors.forename: Feng-ji
authors.initials: FJ
authors.lastname: Luo
authors.forename: Wei
authors.initials: W
authors.lastname: Zhao
authors.forename: Zhao-li
authors.initials: ZL
authors.lastname: Zeng
authors.forename: Yun-hua
authors.initials: YH
authors.lastname: Bai
authors.forename: Ling-li
authors.initials: LL
authors.lastname: Sun
authors.forename: Wei
authors.initials: W
authors.lastname: Xu
mesh_terms: D000914:Antibodies, Viral / Q000032:analysis; D002681:China; D005260:Female; D017325:Hepatitis B Vaccines / Q000276:immunology*; D006801:Humans; D007117:Immunization, Secondary; D007156:Immunologic Memory; D008297:Male; D013334:Students; D014495:Universities
chemical_list: D000914:Antibodies, Viral; D017325:Hepatitis B Vaccines